C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/13 (2006.01) A61K 39/42 (2006.01) C07K 16/08 (2006.01) C07K 16/10 (2006.01) C12N 5/10 (2006.01) C12N 5/28 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2168230
The invention provides human monoclonal antibodies specific for the glycoprotein II subunit of Varicella-zoster virus. Preferred antibodies exhibit strong complement-independent neutralizing activity, antibody dependent cellular cytotoxicity, and cross-reactivity with multiple strains of Varicella-zoster virus.
L'invention porte sur des anticorps humains monoclonaux spécifiques de la sous-unité de la glycoprotéine II du virus varicelle-zona. Les anticorps préférés présentent une forte activité neutralisante indépendante du complément, une cytoxicité cellulaire dépendant de l'anticorps et une réactivité croisée avec de nombreuses souches du virus varicelle-zona.
Lake Philip
Ostberg Lars
Fetherstonhaugh & Co.
Sandoz Pharmaceuticals Corporation
LandOfFree
Human antibodies against varicella-zoster virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human antibodies against varicella-zoster virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human antibodies against varicella-zoster virus will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1564535